Angiogenesis is considered as one of the most important pathways in carcinogenesis, thus the major target in cancer therapy. In this article we will discuss recent studies about the contribution of stroma and bone-marrow derived cells to the regulation of tumor angiogenesis, which provide new directions of novel anti-angiogenesis strategies. Also we will briefly discuss the current available anti-angiogenesis therapies.